Background
Because of the limitations of creatinine (Cr) as a marker for the glomerular filtration rate (GFR), cystatin C (CysC) has
been proposed as an alternative substance. The aim here was to clarify the characteristics of CysC compared with Cr.
Methods
CysC and Cr were measured in 199 patients with chronic kidney disease. Regression analysis between CysC and Cr and comparisons
of the effect of gender, inflammation, prescription of prednisolone, smoking and diabetes mellitus (DM) on these markers were
performed. Sensitivity and specificity of CysC and Cr to discriminate estimated GFR of less than 50 ml/min/1.73 m2 were computed and evaluated by the receiver-operating characteristic curve (ROC).
Results
The correlation coefficient between natural logarithmic Cr [ln(Cr)] and ln(CysC) was higher than that between these variables
per se (0.941 vs. 0.906). When Cr was lower than 1.10 mg/dl, CysC rose more sharply than Cr. CysC divided by Cr (CysC/Cr)
was higher in females (1.35 ± 0.33 vs. 1.16 ± 0.30; p < 0.001), in patients with elevated CRP (1.33 ± 0.40 vs. 1.21 ± 0.29; p < 0.001) and in patients prescribed with prednisolone (1.42 ± 0.33 vs. 1.20 ± 0.30; p < 0.001). A stepwise multiple linear regression model indicated that ln(CysC) was positively correlated with ln(Cr), age,
female gender, prednisolone prescription, elevated CRP and DM (R = 0.964, p < 0.001). The area under the ROC curve of Cr was 0.900 and that of CysC was 0.925.
Conclusion
CysC is a promising marker for GFR because it was not gender- or age-related. However, inflammation, prednisolone and DM caused
CysC to deviate higher than expected from GFR. CysC can rise sensitively in early renal dysfunction.
Keywords CKD - Creatinine - Cystatin C - Renal function
Part of this work was presented at the 37th Western Regional Meeting of the Japanese Society for Nephrology in 2007 at Fukui,
Japan. The last author, Eri Muso M.D., Ph.D., has affiliations as follows: Vice Director of Research Institute, Director of
the Division of Nephrology and Dialysis Kitano Hospital, The Tazuke Kofukai Medical Research Institute, Osaka, Japan.